{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:03Z","timestamp":1786980543571,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10096-019-03468-4","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T22:17:51Z","timestamp":1548368271000},"page":"755-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-192X","authenticated-orcid":false,"given":"Maristela P.","family":"Freire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroti","family":"de Oliveira Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Cury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela R.","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathamy F.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Spad\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda Campagnari","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Henrique","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio J.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willian C.","family":"Nahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"David-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia C.","family":"Pierrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"3468_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.trre.2017.07.001","volume":"32","author":"JM Aguado","year":"2018","unstructured":"Aguado JM, Silva JT, Fern\u00e1ndez-Ruiz M, Cordero E, Fort\u00fan J, Gudiol C, Mart\u00ednez-Mart\u00ednez L, Vidal E, Almenar L, Almirante B, Cant\u00f3n R, Carratal\u00e1 J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fern\u00e1ndez J, Fari\u00f1as MC, Gavald\u00e0 J, Goyanes MJ, Guti\u00e9rrez-Guti\u00e9rrez B, Hern\u00e1ndez D, Len O, L\u00f3pez-Andujar R, L\u00f3pez-Medrano F, Mart\u00edn-D\u00e1vila P, Montejo M, Moreno A, Oliver A, Pascual A, P\u00e9rez-Nadales E, Rom\u00e1n-Broto A, San-Juan R, Ser\u00f3n D, Sol\u00e9-Jover A, Valerio M, Mu\u00f1oz P, Torre-Cisneros J (2018) Management of multidrug resistant gram-negative bacilli infections in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations. Transplant Rev 32:36\u201357","journal-title":"Transplant Rev"},{"key":"3468_CR2","first-page":"1","volume":"3099","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Pa\u00f1o-Pardo JR, Venditti M, Tumbarello M, Daikos G, Cant\u00f3n R, Doi Y, Tuon FF, Karaiskos I, P\u00e9rez-Nadales E, Schwaber MJ, Azap \u00d6K, Souli M, Roilides E, Pournaras S, Akova M, P\u00e9rez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodr\u00edguez-Ba\u00f1o J (2017) Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis 3099:1\u20139","journal-title":"Lancet Infect Dis"},{"key":"3468_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s15010-015-0743-4","volume":"43","author":"MP Freire","year":"2015","unstructured":"Freire MP, Abdala E, Moura ML, de Paula FJ, Spad\u00e3o F, Caiaffa-Filho HH, David-Neto E, Nahas WC, Pierrotti LC (2015) Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection 43:315\u2013323","journal-title":"Infection"},{"key":"3468_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/tid.12276","volume":"16","author":"J Simkins","year":"2014","unstructured":"Simkins J, Muggia V, Cohen HW, Minamoto GY (2014) Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study. Transpl Infect Dis 16:775\u2013782","journal-title":"Transpl Infect Dis"},{"key":"3468_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12757","volume":"19","author":"G Varotti","year":"2017","unstructured":"Varotti G, Dodi F, Terulla A, Santori G, Bertocchi M, Marchese A, Fontana I, Unit KT (2017) Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation. Transpl Infect Dis 19:e12757","journal-title":"Transpl Infect Dis"},{"key":"3468_CR6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s10096-015-2486-7","volume":"34","author":"LEB Nabarro","year":"2015","unstructured":"Nabarro LEB, Veeraraghavan B (2015) Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions. Eur J Clin Microbiol Infect Dis 34:2307\u20132311","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3468_CR7","doi-asserted-by":"crossref","unstructured":"Jeannot K, Bolard A, Pl\u00e9siat P (2017) Resistance to polymyxins in gram-negative organisms. Int J Antimicrob Agents","DOI":"10.1016\/j.ijantimicag.2016.11.029"},{"key":"3468_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bjm.2016.10.002","volume":"47","author":"JLM Sampaio","year":"2016","unstructured":"Sampaio JLM, Gales AC (2016) Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on \u03b2-lactams and polymyxins. Brazilian J Microbiol 47:31\u201337","journal-title":"Brazilian J Microbiol"},{"key":"3468_CR9","unstructured":"2017. CDC\/NHSN surveillance definitions for specific types of infections"},{"key":"3468_CR10","unstructured":"EUCAST. 2017. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoints tables for interpretation of MICs and zone diameters. Version 7.0"},{"key":"3468_CR11","unstructured":"CLSI. 2017. Performance standards for antimicrobial susceptibility testing. 27th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute"},{"key":"3468_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119\u2013123","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3468_CR13","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1128\/AAC.02108-12","volume":"57","author":"MFC Bueno","year":"2013","unstructured":"Bueno MFC, Francisco GR, O\u2019Hara JA, De Oliveira Garcia D, Doi Y (2013) Coproduction of 16S rRNA methyltransferase RmtD or RmtG with KPC-2 and CTX-M group extended-spectrum \u03b2lactamases in Klebsiella pneumoniae. Antimicrob Agents Chemother 57:2397\u20132400","journal-title":"Antimicrob Agents Chemother"},{"key":"3468_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/518605","volume":"45","author":"Y Doi","year":"2007","unstructured":"Doi Y, Arakawa Y (2007) 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88\u201394","journal-title":"Clin Infect Dis"},{"key":"3468_CR15","doi-asserted-by":"crossref","unstructured":"Gautom RK. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157: H7 and other gram-negative organisms in 1 day 35:2977\u20132980","DOI":"10.1128\/JCM.35.11.2977-2980.1997"},{"key":"3468_CR16","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1093\/jac\/dkw178","volume":"71","author":"JT Seroy","year":"2016","unstructured":"Seroy JT, Grim SA, Reid GE, Wellington T, Clark NM (2016) Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis. J Antimicrob Chemother 71:2563\u20132568","journal-title":"J Antimicrob Chemother"},{"key":"3468_CR17","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/j.transproceed.2014.09.160","volume":"46","author":"E Mouloudi","year":"2014","unstructured":"Mouloudi E, Massa E, Piperidou M, Papadopoulos S, Iosifidis E, Roilides I, Theodoridou T, Kydona C, Fouzas I, Imvrios G, Papanikolaou V, Gritsi-Gerogianni N (2014) Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study. Transplant Proc 46:3219\u20133221","journal-title":"Transplant Proc"},{"key":"3468_CR18","doi-asserted-by":"crossref","unstructured":"Freire MP, Oshiro ICVS, Pierrotti LC, Bonazzi PR, De Oliveira LM, Song ATW, Camargo CH, Van Der Heijden IM, Rossi F, Costa SF, D\u2019Albuquerque LAC, Abdala E (2017) Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation 101","DOI":"10.1097\/TP.0000000000001620"},{"key":"3468_CR19","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/ajt.13136","volume":"15","author":"M Giannella","year":"2015","unstructured":"Giannella M, Bartoletti M, Morelli MC, Tedeschi S, Cristini F, Tumietto F, Pasqualini E, Danese I, Campoli C, Di Lauria N, Faenza S, Ercolani G, Lewis R, Pinna AD, Viale P (2015) Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant 15:1708\u20131715","journal-title":"Am J Transplant"},{"key":"3468_CR20","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/jac\/dkv086","volume":"70","author":"M Tumbarello","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, Maiuro G, Tedeschi S, Celani L, Cardellino CS, Spanu T, Marchese A, Ambretti S, Cauda R, Viscoli C, Viale P (2015) Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 70:2133\u20132143","journal-title":"J Antimicrob Chemother"},{"key":"3468_CR21","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1128\/AAC.01071-15","volume":"59","author":"S Sastry","year":"2015","unstructured":"Sastry S, Clarke LG, Alrowais H, Querry AM, Shutt KA, Doi Y (2015) Clinical appraisal of fosfomycin in the era of antimicrobial resistance. Antimicrob Agents Chemother 59:7355\u20137361","journal-title":"Antimicrob Agents Chemother"},{"key":"3468_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1128\/AAC.01235-09","volume":"54","author":"A Endimiani","year":"2010","unstructured":"Endimiani A, Patel G, Hujer KM, Swaminathan M, Perez F, Rice LB, Jacobs MR, Bonomo RA (2010) In vitro activity of Fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and\/or colistin. Antimicrob Agents Chemother 54:526\u2013529","journal-title":"Antimicrob Agents Chemother"},{"key":"3468_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12795","volume":"20","author":"R Rosa","year":"2018","unstructured":"Rosa R, Rudin SD, Rojas LJ, Hujer AM, Perez-Cardona A, Perez F, Bonomo RA, Martinez O, Abbo LM, Camargo JF (2018) \u201cDouble carbapenem\u201d and oral fosfomycin for the treatment of complicated urinary tract infections caused by bla NDM -harboring Enterobacteriaceae in kidney transplantation. Transpl Infect Dis 20:e12795","journal-title":"Transpl Infect Dis"},{"key":"3468_CR24","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1128\/AAC.00741-13","volume":"58","author":"T T\u00e4ngd\u00e9n","year":"2014","unstructured":"T\u00e4ngd\u00e9n T, Hickman RA, Forsberg P, Lagerb\u00e4ck P, Giske CG, Cars O (2014) Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments. Antimicrob Agents Chemother 58:1757\u20131762","journal-title":"Antimicrob Agents Chemother"},{"key":"3468_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/phar.1924","volume":"37","author":"AA Loethen","year":"2017","unstructured":"Loethen AA, Kerstenetzky L, Descourouez JL, Leverson GE, Smith JA, Jorgenson MR (2017) Fosfomycin for the treatment of cystitis in the abdominal solid organ transplant population. Pharmacotherapy 37:599\u2013606","journal-title":"Pharmacotherapy"},{"key":"3468_CR26","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s10096-017-2936-5","volume":"36","author":"M Souli","year":"2017","unstructured":"Souli M, Karaiskos I, Masgala A, Galani L, Barmpouti E, Giamarellou H (2017) Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 36:1305\u20131315","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3468_CR27","first-page":"1","volume":"0","author":"EA Neuner","year":"2016","unstructured":"Neuner EA, Gallagher JC (2016) Pharmacodynamic and pharmacokinetic considerations in the treatment of critically ill patients infected with carbapenem-resistant Enterobacteriaceae. Virulence 0:1\u201313","journal-title":"Virulence"},{"key":"3468_CR28","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1128\/AAC.00655-15","volume":"59","author":"JF Camargo","year":"2015","unstructured":"Camargo JF, Simkins J, Beduschi T, Tekin A, Aragon L, P\u00e9rez-Cardona A, Prado CE, Morris MI, Abbo LM, Cant\u00f3n R (2015) Successful treatment of carbapenemase-producing pandrug-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother 59:5903\u20135908","journal-title":"Antimicrob Agents Chemother"},{"key":"3468_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijid.2015.01.011","volume":"33","author":"A Oliva","year":"2015","unstructured":"Oliva A, Mascellino MT, Cipolla A, Abramo AD, De Rosa A, Savinelli S, Rosa M, Mastroianni CM (2015) Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen. Int J Infect Dis 33:132\u2013134","journal-title":"Int J Infect Dis"},{"key":"3468_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1769-z","volume":"21","author":"G Pascale De","year":"2017","unstructured":"De Pascale G, Martucci G, Montini L, Panarello G, Cutuli SL, Di Carlo D, Di Gravio V, Di Stefano R, Capitanio G, Vallecoccia MS, Polidori P, Spanu T, Arcadipane A, Antonelli M (2017) Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study. Crit Care 21:1\u201310","journal-title":"Crit Care"},{"key":"3468_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/23744235.2017.1350880","volume":"49","author":"V Venugopalan","year":"2017","unstructured":"Venugopalan V, Nogid B, Le TN, Rahman SM, Bias TE (2017) Double carbapenem therapy (DCT) for bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP): from test tube to clinical practice. Infect Dis (Auckl) 49:867\u2013870","journal-title":"Infect Dis (Auckl)"},{"key":"3468_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1128\/AAC.01569-15","volume":"60","author":"JB Cprek","year":"2015","unstructured":"Cprek JB, Gallagher JC (2015) Ertapenem-containing double-carbapenem therapy for treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 60:669\u2013673","journal-title":"Antimicrob Agents Chemother"},{"key":"3468_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","volume":"66","author":"D Duin Van","year":"2017","unstructured":"Van Duin D, Lok JJ, Earley M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Jr VGF, Paterson DL, Bonomo RA, Evans S (2017) Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 66:163\u2013171","journal-title":"Clin Infect Dis"},{"key":"3468_CR34","first-page":"1","volume":"61","author":"RK Shields","year":"2017","unstructured":"Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV, Doi Y, Kreiswirth BN, Clancy CJ (2017) Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother 61:1\u20137","journal-title":"Antimicrob Agents Chemother"},{"key":"3468_CR35","doi-asserted-by":"crossref","unstructured":"Shields RK, Clancy CJ, Press EG, Hong M. 2016. Aminoglycosides for treatment of bacteremia due to carbapenem-resistant Klebsiella pneumoniae 60:3187\u20133192","DOI":"10.1128\/AAC.02638-15"},{"key":"3468_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bjid.2012.10.016","volume":"17","author":"CS Abboud","year":"2013","unstructured":"Abboud CS, Bergamasco MD, De Sousa EE, De C\u00e1ssia Zandonadi E, Cortez D (2013) Successful use of gentamycin as an antibiotic prophylaxis regimen to reduce the rate of healthcare-associated infections after renal transplantation. Brazilian J Infect Dis 17:254\u2013255","journal-title":"Brazilian J Infect Dis"},{"key":"3468_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jac\/dku432","volume":"70","author":"M Gonzalez-Padilla","year":"2015","unstructured":"Gonzalez-Padilla M, Torre-Cisneros J, Rivera-Espinar F, Pontes-Moreno A, L\u00f3pez-Cerero L, Pascual A, Natera C, Rodr\u00edguez M, Salcedo I, Rodr\u00edguez-L\u00f3pez F, Rivero A, Rodr\u00edguez-Ba\u00f1o J (2015) Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae. J Antimicrob Chemother 70:905\u2013913","journal-title":"J Antimicrob Chemother"},{"key":"3468_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","volume":"30","author":"Y Doi","year":"2016","unstructured":"Doi Y, Wachino J, Arakawa Y (2016) Aminoglycoside resistance. Infect Dis Clin N Am 30:523\u2013537","journal-title":"Infect Dis Clin N Am"},{"key":"3468_CR39","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1111\/j.1469-0691.2011.03738.x","volume":"18","author":"I Galani","year":"2012","unstructured":"Galani I, Souli M, Panagea T, Poulakou G, Kanellakopoulou K, Giamarellou H (2012) Prevalence of 16S rRNA methylase genes in Enterobacteriaceae isolates from a Greek university hospital. Clin Microbiol Infect 18:E52\u2013E54","journal-title":"Clin Microbiol Infect"},{"key":"3468_CR40","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s10096-010-1004-1","volume":"29","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, Guo Y, Wang M (2010) Distribution of 16S rRNA methylases among different species of gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis 29:1349\u20131353","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03468-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T19:18:05Z","timestamp":1579807085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03468-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3468"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03468-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by our Institutional Review Board and due to its retrospective study design, patient informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}